Primary care of the patient with chronic obstructive pulmonary disease in Italy

被引:23
作者
Cazzola, Mario [1 ]
Bettoncelli, Germano [2 ]
Sessa, Emiliano [2 ]
Cricelli, Claudio [2 ]
机构
[1] Univ Roma Tor Vergata, Dept Internal Med, Unit Resp Dis, I-00133 Rome, Italy
[2] Italian Coll Gen Practitioners, Hlth Search Inst, Florence, Italy
关键词
COPD; Primary care; Management; GENERAL-PRACTITIONERS; COPD; MANAGEMENT; SPIROMETRY; DIAGNOSIS; SALMETEROL; GUIDELINES; PATTERNS; ASTHMA; THEOPHYLLINE;
D O I
10.1016/j.rmed.2008.10.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Using a general practice research database with general. practitioner (GP) clinical. records, it has been observed that among the 617,280 subjects registered with 400 Italian GPs, 15,229 (2.47%) patients were suffering from chronic obstructive pulmonary disease (COPD). Of these, 67.7% had a chest radiograph at least once in a period of 10 years (1997-2006), while in the same period only 31.9% had a spirometry, 29.9% had a visit to a specialist, and 0.94% had a visit to an allergologist. From 1997 to 2006, 7.5% of patients with COPD, especially the oldest ones, were hospitalized at least once for the disease, although 44.0% of all. patients with COPD were hospitalized for other pathologies. With regard to treatment, in 2006, 10,936 (71.1%) of COPD patients received at least one drug for their disease (drugs classified within the R03 therapeutic pharmacological subgroup of the Anatomical Therapeutic Chemical Classification). In particular, salmeterol/fluticasone was prescribed 6441 times, tiotropium 4962, theophylline 3142, beclomethasone 2853, salbutamol 2256, formoterol 2191, salbutamol/beclomethasone 2129, oxitropium 1802 and formoterol/budesonide 1741 times. Based on these findings, the level of COPD management in Italy seems to fall short of recommended international COPD guidelines. In particular, it appears that GPs usually prescribe treatment without the use of spirometry, and/or without taking into account the severity of airway obstruction. It must also be noted that, in general, patients with COPD are undertreated. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:582 / 588
页数:7
相关论文
共 45 条
[1]  
[Anonymous], THORAX
[2]  
[Anonymous], WHO COLL CTR DRUG ST
[3]  
[Anonymous], 1977, INT CLASS DIS MAN IN
[4]   Role of primary care in early diagnosis and effective management of COPD [J].
Bellamy, D. ;
Smith, J. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (08) :1380-1389
[5]   Practice patterns in the management of chronic obstructive pulmonary disease in primary practice: The CAGE study [J].
Bourbeau, Jean ;
Sebaldt, Rolf J. ;
Day, Anna ;
Bouchard, Jacques ;
Kaplan, Alan ;
Hernandez, Paul ;
Rouleau, Michel ;
Petrie, Annie ;
Foster, Gary ;
Thabane, Lehana ;
Haddon, Jennifer ;
Scalera, Alissa .
CANADIAN RESPIRATORY JOURNAL, 2008, 15 (01) :13-19
[6]  
Caramori G, 2005, Monaldi Arch Chest Dis, V63, P6
[7]  
Caramori G, 2007, Monaldi Arch Chest Dis, V67, P15
[8]   Lung function improvement in smokers suffering from COPD with zafirlukast, a CysLT1-receptor antagonist [J].
Cazzola, M ;
Centanni, S ;
Boveri, B ;
Carlucci ;
Santus, P ;
DiMarco, F ;
Allegra, L .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2000, 13 (06) :301-305
[9]   Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia [J].
Cazzola, M ;
Imperatore, F ;
Salzillo, A ;
Di Perna, F ;
Calderaro, F ;
Imperatore, A ;
Matera, MG .
CHEST, 1998, 114 (02) :411-415
[10]   Additive effects of salmeterol and fluticasone or theophylline in COPD [J].
Cazzola, M ;
Di Lorenzo, G ;
Di Perna, F ;
Calderaro, F ;
Testi, R ;
Centanni, S .
CHEST, 2000, 118 (06) :1576-1581